April 27, 2021
NanoCarrier and Axcelead have launched a joint venture named PrimRNA to carry out research on articular cartilage therapies harnessing NanoCarrier’s mRNA technology, which was selected under the Japan Agency for Medical Research and Development’s (AMED) Cyclic Innovation for Clinical Empowerment...read more